서브이미지

About Us

연혁

Growth

  • Listed on the KOSDAQ market in 2015.
  • Acquisition of Sungwoon Bio in 2017 (currently GF Permanentech)
Growth 이미지
technology
Competitiveness in commercializing customized enzymes.
- Speed up enzyme development (3 years → 1 year)
- Fermented production of 150 tons.
sales
Securing excellent customers and launching customized enzyme products.
Leaping into a new bio drug developer
2020
  • 08 Development of human disease models such as IBD and Wet AMD using mini pigs.
  • 08 Development of Proteinase-K, an essential enzyme for COVID-19 diagnosis.
  • 02 10 billion won worth of investment attraction.
2018
  • 10 Establishment of BiomLogic, a subsidiary specializing in new drug development.
2017
  • 06 Discovered GF103 as a candidate for pharmaceutical products.
  • 03 Acquisition of Sungwoon Bio (currently GF Permanentech)
2016
  • 11 Lactase US FDA GRAS acknowledged.
  • 10 30.8 billion won worth of investment attraction.
2015
  • 05 KOSDAQ Market Listed
2013
  • 08 Hydrogen peroxide decomposition enzyme in the semiconductor factory cleaning solution. Sales of Katalase S 350L started.
2012
  • 05 Establishment of 100% subsidiary in China. (GenoFocus Biotechnology Ltd.)

Take-off

  • Development of Catalase mass production process in 2010
Take-off 이미지
technology
Customized enzyme development and production technology.
- Enzyme improvement technology
- recombinant protein secretion technology
sales
Service & customized enzyme.
2011
  • 11 Sales of hydrogen peroxide decomposition enzyme for fibers, Katalase S, started.
  • 10 A contract to transfer GOS production technology to Q (USD 600,000)
2010
  • 11 Completed development of TL Lipase production technology for manufacturing raw materials and medicines.
  • 11 Catalase mass production process development completed.
2008
  • 12 Selection of civil and military technology development project (Defense Project Administration)
    Development of eco-friendly decontamination agents for chemical/biological weapons.

Establishment

  • 2001 certification as a venture company.
  • Selected as INNO-BIZ company in 2002.
Establishment 이미지
technology
Customized protein development platform technology.
-Molecular evolution technology
- Display technology
sales
Technology service.
2004
  • 10 2nd CEO inauguration: Kim Uijung
2002
  • 12INNO-BIZ company selection.
2001
  • 05 Selected as a nationally designated laboratory by the Ministry of Science and Technology: Microbial display platform technology
  • 02 Certification of venture companies.
2000
  • 03Korea Biotechnology Research Institute spin-off.
    (Organizer: Ban Jaegu, current CTO)